Academic literature on the topic 'Zhao gao zou yi lei'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Zhao gao zou yi lei.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Zhao gao zou yi lei"

1

Zhu, Chaodong, Arong Luo, Ming Bai, et al. "A joint call for actions to advance taxonomy in China." Zoological Systematics 47, no. 3 (2022): 188–97. https://doi.org/10.11865/zs.2022302.

Full text
Abstract:
Zhu, Chaodong, Luo, Arong, Bai, Ming, Orr, Michael C., Hou, Zhonge, Ge, Siqin, Chen, Jun, Hu, Yibo, Zhou, Xuming, Qiao, Gexia, Kong, Hongzhi, Lu, Limin, Jin, Xiaohua, Cai, Lei, Wei, Xinli, Zhao, Ruilin, Miao, Wei, Wang, Qingfeng, Sha, Zhongli, Lin, Qiang, Qu, Meng, Jiang, Jianping, Li, Jiatang, Che, Jing, Jiang, Xuelong, Chen, Xiaoyong, Gao, Lianming, Ren, Zongxin, Xiang, Chunlei, Luo, Shixiao, Wu, Donghui, Liu, Dong, Peng, Yanqiong, Su, Tao, Cai, Chenyang, Zhu, Tianqi, Cai, Wanzhi, Liu, Xingyue, Li, Hu, Xue, Huaijun, Ye, Zhen, Chen, Xuexin, Tang, Pu, Wei, Shujun, Pang, Hong, Xie, Qiang, Zhang
APA, Harvard, Vancouver, ISO, and other styles
2

Lin, Ying-Yi, Hong-Fei Gao, Hong Li, et al. "Abstract PO1-06-01: Clinical Efficacy of Tumor Organoid-Guided Cancer Therapy for Locally Advanced Unresectable or Metastatic Breast Cancer." Cancer Research 84, no. 9_Supplement (2024): PO1–06–01—PO1–06–01. http://dx.doi.org/10.1158/1538-7445.sabcs23-po1-06-01.

Full text
Abstract:
Abstract Purpose: Patient-derived organoids (PDOs) may facilitate treatment selection, but the feasibility of using breast cancer PDOs to guide personalized treatment in clinical practice has not been fully investigated. This study aimed to assess the clinical efficacy of treatment guided by PDO drug sensitivity tests (OGT) versus treatment of physician’s choice (TPC) in patients with locally advanced unresectable or metastatic breast cancer (MBC) and to explore the potential of PDOs to reveal mechanisms underlying treatment resistance. Methods: Patients diagnosed with MBC were recruited betwe
APA, Harvard, Vancouver, ISO, and other styles
3

Chen, Xu-Xing, Qian-Qian Shen, Zhao Zhao, et al. "Abstract 5436: HH2853 is a selective small molecular dual inhibitor of EZH1/2 with potent anti-tumor activities." Cancer Research 82, no. 12_Supplement (2022): 5436. http://dx.doi.org/10.1158/1538-7445.am2022-5436.

Full text
Abstract:
Abstract Polycomb Repressive Complex 2 (PRC2) is a multiprotein complex that catalyzes the methylation of lysine 27 on histone H3 (H3K27), and the histone methyltransferases EZH1/2 are the catalytic subunit of PRC2. Aberrant activation of EZH2 drives H3K27 methylation and plays a critical role in cancer initiation and progression. Meanwhile, loss-of-function mutation in the major components of SWI/SNF complex leads to a loss of its suppression ability against PRC2 and subsequently activates EZH2. Targeting EZH2 has been validated as a promising therapeutic strategy for cancer treatment, especi
APA, Harvard, Vancouver, ISO, and other styles
4

Chen, Li, Yi-Zhou Jiang, Songyang Wu, et al. "Abstract P2-14-04: Updated data from FUTURE-C-PLUS: Combination of famitinib with camrelizumab plus nab-paclitaxel as first-line treatment for advanced, immunomodulatory triple-negative breast cancer, an open-label, single-arm, phase 2 trial." Cancer Research 82, no. 4_Supplement (2022): P2–14–04—P2–14–04. http://dx.doi.org/10.1158/1538-7445.sabcs21-p2-14-04.

Full text
Abstract:
Abstract Background Camrelizumab and nab-paclitaxel demonstrated promising anti-tumour activity in refractory metastatic immunomodulatory triple-negative breast cancer (TNBC) in FUTURE trial. Anti-angiogenic agents have been reported to facilitate immune infiltration. Famitinib is a tyrosine kinase inhibitor targeting VEGFR-2, PDGFR and c-kit. The FUTURE-C-PLUS trial (NCT04129996) which added famitinib to camrelizumab and nab-paclitaxel is a single-arm, phase 2 trial evaluating this novel triplet combinatorial strategy in patients with advanced immunomodulatory TNBC. Study design and the prima
APA, Harvard, Vancouver, ISO, and other styles
5

Lei, Jonathan T., Sara R. Savage, Xinpei Yi, et al. "Abstract 5726: Pan-cancer proteogenomics expands the landscape of therapeutic targets." Cancer Research 83, no. 7_Supplement (2023): 5726. http://dx.doi.org/10.1158/1538-7445.am2023-5726.

Full text
Abstract:
Abstract Background: Molecularly targeted therapies are critical for improving cancer treatment. Since proteins are the targets of these therapies and functional effectors of genomic aberrations, proteogenomics data from the Clinical Proteomics Tumor Analysis Consortium (CPTAC) provides an unprecedented opportunity to characterize existing and future therapeutic targets for cancer treatment. Approach: CPTAC proteogenomics data from >1000 cancer patients spanning 10 cancer types was used to evaluate current and potential therapeutic targets curated from four databases. Cell line data fro
APA, Harvard, Vancouver, ISO, and other styles
6

Чэнь, Ш. "АЛЕАТОРИКА В ФОРТЕПИАННОЙ МУЗЫКЕ КИТАЙСКИХ КОМПОЗИТОРОВ РУБЕЖА XX–XXI ВЕКОВ". АКТУАЛЬНЫЕ ПРОБЛЕМЫ ВЫСШЕГО МУЗЫКАЛЬНОГО ОБРАЗОВАНИЯ, № 3(57) (30 вересня 2020). https://doi.org/10.26086/nk.2020.57.3.017.

Full text
Abstract:
С 1980-х годов многие китайские композиторы обращаются к авангардным техникам для воплощения актуальных идей своего времени. В фортепианном творчестве Ло Чжунжуна, Чэнь Минчжи, Яо Хэнлу, Чжао Сяошэна широко представлены композиции в серийной и сериальной техниках; неофольклорные тенденции наблюдаются в ранних произведениях для фортепиано Чэнь И, Чжоу Луна; ярко заявила о себе сонористика в творчестве Тан Дуна, Лян Лэя, Чэнь Сяоюна. В этом разнообразии направлений алеаторика нашла довольно скромное применение — в ряде фортепианных опусов Тан Дуна, Цао Гуанпина, Гао Пина, которые стали объектом
APA, Harvard, Vancouver, ISO, and other styles
7

"MSOM Society Student Paper Competition: Abstracts of 2024 Winners." Manufacturing & Service Operations Management 27, no. 3 (2025): xviii—xx. https://doi.org/10.1287/msom.2025.studentabs.v27.n3.

Full text
Abstract:
The journal is pleased to publish the abstracts of the four finalists of the 2024 Manufacturing and Service Operations Management Society’s student paper competition. The 2024 prize committee was chaired by Vasiliki Kostami (HEC), Simone Marinesi (Wharton), and Fanyin Zheng (Imperial). The judges were Abhishek Deshmane, Agni Orfanoudaki, Alp Akcay, Alper Nakkas, Amrita Kundu, Antoine Desir, Anton Ovchinnikov, Anyan Qi, Ashish Kabra, Auyon Siddiq, Benjamin Legros, Bilal Gokpinar, Bin Hu, Bob Batt, Bora Keskin, Brent Moritz, Can Zhang, Chiara Farronato, Chloe Glaeser, Christopher Chen, Cuihong L
APA, Harvard, Vancouver, ISO, and other styles
8

Thanh Huyen, Le, Dao Sy Duc, Nguyen Xuan Hoan, Nguyen Huu Tho, and Nguyen Xuan Viet. "Synthesis of Fe3O4-Reduced Graphene Oxide Modified Tissue-Paper and Application in the Treatment of Methylene Blue." VNU Journal of Science: Natural Sciences and Technology 35, no. 3 (2019). http://dx.doi.org/10.25073/2588-1140/vnunst.4883.

Full text
Abstract:
Graphene-based composites have received a great deal of attention in recent year because the presence of graphene can enhance the conductivity, strength of bulk materials and help create composites with superior qualities. Moreover, the incorporation of metal oxide nanoparticles such as Fe3O4 can improve the catalytic efficiency of composite material. In this work, we have synthesized a composite material with the combination of reduced graphene oxide (rGO), and Fe3O4 modified tissue-paper (mGO-PP) via a simple hydrothermal method, which improved the removal efficiency of the of methylene blue
APA, Harvard, Vancouver, ISO, and other styles
9

Dolomatov, S.I., та W. Zukow. "Эпигенетика почек = Kidneys epigenetics". 7 липня 2019. https://doi.org/10.5281/zenodo.3270754.

Full text
Abstract:
<strong>Dolomatov S.I., Zukow W. </strong><strong>Эпигенетика почек</strong><strong> = Kidney</strong><strong>s</strong><strong> epigenetics</strong><strong>. </strong><strong>RSW. Radom,</strong><strong> 144 </strong><strong>p. ISBN </strong><strong>9780359774524</strong><strong>.</strong><strong> DOI </strong><strong>http://dx.doi.org/10.5281/zenodo.3270699</strong><strong> PBN Poland </strong><strong>https://pbn.nauka.gov.pl/sedno-webapp/works/917606</strong> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <strong>Radomska Szkoła Wyższa w Radomiu, Radom, Poland</strong> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Zhao gao zou yi lei"

1

Beijing jiao yu kao shi yuan. Quan guo pu tong gao deng xue xiao zai Jing zhao sheng lu qu fen shu fen bu tong ji ( li ke ).: Ti qian pi ci (han yi zhu lei ti qian pi ) ji ben ke lu qu bu fen. Beijing li gong ta xue chu ban she, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Yan Zhao jing lei: Zheng qu Gao Shuxun qi yi ji shi. Jie fang jun chu ban she, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Suojia ri ji: Yi ge nü ren lei xue jia zai Miao zhai de kao cha. Xue yuan chu ban she, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

"Zheng ce zhu dao xing" de jian jin shi gai ge: Gai ge kai fang yi lai Zhongguo zheng zhi fa zhan de yin su fen xi. Zhongguo she hui ke xue chu ban she, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!